Globus Medical (GMED) Misses Q1 EPS by 5c, Confirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Globus Medical Reports First Quarter 2019 Results
May 2, 2019 4:18 PM EDTAUDUBON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019.
Worldwide sales were $182.9 million, an increase of 4.9% as reportedFirst quarter net income was $33.2 million, a decrease of 16.0%Diluted earnings per share (EPS) was $0.33 and non-GAAP diluted EPS was $0.36Non-GAAP diluted EPS decreased 13.4% compared to first quarter of 2018Non-GAAP adjusted EBITDA was 31.1% of salesOur first quarter results demonstrate continued strong momentum in... More
